Induced Pluripotent Stem Cells and Their Use in Human Models of Disease and Development.
Karagiannis P; Takahashi K; Saito M; Yoshida Y; Okita K; Watanabe A; Inoue H; Yamashita JK; Todani M; Nakagawa M; Osawa M; Yashiro Y; Yamanaka S; Osafune K
Physiological reviews, Jan. 2019, Peer-reviewed
Repurposing the Cord Blood Bank for Haplobanking of HLA-Homozygous iPSCs and Their Usefulness to Multiple Populations.
Suji Lee; Ji Young Huh; David M Turner; Soohyeon Lee; James Robinson; Jeremy E Stein; Sung Han Shim; Chang Pyo Hong; Myung Seo Kang; Masato Nakagawa; Shin Kaneko; Mahito Nakanishi; Mahendra S Rao; Andreas Kurtz; Glyn N Stacey; Steven G E Marsh; Marc L Turner; Jihwan Song
Specific lectin biomarkers for isolation of human pluripotent stem cells identified through array-based glycomic analysis
Yu-Chieh Wang; Masato Nakagawa; Ibon Garitaonandia; Ileana Slavin; Gulsah Altun; Robert M. Lacharite; Kristopher L. Nazor; Ha T. Tran; Candace L. Lynch; Trevor R. Leonardo; Ying Liu; Suzanne E. Peterson; Louise C. Laurent; Shinya Yamanaka; Jeanne F. Loring
CELL RESEARCH, Nov. 2011, Peer-reviewed
Integration-Free iPS Cells Engineered Using Human Artificial Chromosome Vectors
Modeling Charcot-Marie-Tooth disease using patient iPSCs
Ohara R; Imamura K; Morii F; Egawa N; Mizuno T; Nakagawa M; Inoue H
58th Annual Meeting of the Japanese Society of Neurology, Kyoto., 16 Sep. 2017
iPSC model for demyelinating Charcot-Marie-Tooth disease
Kitani-Morii F; Imamura K; Kondo T; Ohara R; Yamamoto T; Sekiguchi K; Toguchida J; Mizuno T; Nakagawa M; Inoue H
58th Annual Meeting of the Japanese Society of Neurology, Kyoto., 16 Sep. 2017
Modeling Charcot-Marie-Tooth disease using patient-induced pluripotent stem cells
Morii F; Imamura K; Ohara R; Shibata M; Sekiguchi K; Ikeya M; Toguchida J; Mizuno T; Nakagawa M; Inoue H
57th Annual Meeting of the Japanese Society of Neurology, Kobe., 18 May 2016
Induced pluripotent stem cells derived from idiopathic parkinson’s disease patients differentiate into midbrain dopaminergic neurons and improve motor function of parkinson’s disease model rats
Keisuke OkitaKikuchi T; Morizane A; Doi D; Okita K; Nakagawa M; Inoue H; Takahashi R; Takahashi J
Generation of induced pluripotent stem (iPS) cells by Sox2, Oct4, Klf4, and c-Myc transcription factors \nand their family genes 「The 11th Kyoto University International Symposium 2008」(
Deep Subcellular Proteome Profiling of Human Induced Pluripotent Stem Cell by One-Shot Nanolc-MS/MS Analyses with Meter-Scale Monolithic Silica Columns
Loss of Shall4 Leads to Early Embryonic Lethality in Homozygous Null Mice and Neural Tube Closure Defects and Imperforate Anus in Heterozygous Embryos.
Tsubooka N; Ichisaka T; Nakagawa M; Yamanaka S
The 5th JBS Symposium(2006.3.1. 群馬), 2006
Expression control of the Nanog gene by transcription factors and epigenetic modification.
Maruyama M; Imamura M; Itoh H; Miura K; Ichisaka T; Nakagawa M; Yamanaka S